Prostate Cancer News and Research

RSS
Prostate cancer is the most common non-skin cancer in the United States and the third most common cancer worldwide. More than 1 million men in the United States have prostate cancer and it is the second leading cause of cancer death amongst men after lung cancer. In 2009, an estimated 192,280 new cases are expected to be diagnosed and approximately 27,360 men are expected to die from the disease. Castration-resistant prostate cancer (CRPC) is defined as prostate cancer that continues to grow despite all standard-of-care hormonal (anti-androgen) therapies. Patients with castration-resistant (also known as hormone-refractory) prostate cancer have few treatment options and a poor prognosis.

Further Reading

New blood test can predict drug resistance in patients with advanced prostate cancer

New blood test can predict drug resistance in patients with advanced prostate cancer

Cancer treatment with alternative medicine can double risk of dying: Study finds

Cancer treatment with alternative medicine can double risk of dying: Study finds

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Mayo Clinic researchers discover new cause of treatment resistance in prostate cancer

Researchers develop and validate new assay that detects gene fusions in solid tumors

Researchers develop and validate new assay that detects gene fusions in solid tumors

Symposium explores interaction between age-related cardiovascular dysfunction and diseases

Symposium explores interaction between age-related cardiovascular dysfunction and diseases

Researchers identify gene that could play role in energy requirements of liver cancer cells

Researchers identify gene that could play role in energy requirements of liver cancer cells

Prostate cancer cells gain unnatural ability to change shape and spread

Prostate cancer cells gain unnatural ability to change shape and spread

Mice study shows why women with obesity have more aggressive breast cancer

Mice study shows why women with obesity have more aggressive breast cancer

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

Researchers demonstrate potential of new PET tracer for imaging prostate cancer

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

SNMMI recognizes contributions to nuclear medicine and molecular imaging at 2017 annual meeting

Shaping the future of oncology treatment

Shaping the future of oncology treatment

Expert highlights CRISPR’s applications, limitations, and ethical concerns

Expert highlights CRISPR’s applications, limitations, and ethical concerns

Neuro-oncology scientists discover unique molecular mechanism that maintains glioma stem cells

Neuro-oncology scientists discover unique molecular mechanism that maintains glioma stem cells

Diagnosing prostate cancer through a £225 urine test

Diagnosing prostate cancer through a £225 urine test

Ground-breaking new breast cancer drugs have manageable toxicity profile for most patients

Ground-breaking new breast cancer drugs have manageable toxicity profile for most patients

ASTRO releases updated insurance coverage recommendations for proton beam therapy to treat cancer

ASTRO releases updated insurance coverage recommendations for proton beam therapy to treat cancer

Tall and obese men at increased risk of aggressive prostate cancer, study finds

Tall and obese men at increased risk of aggressive prostate cancer, study finds

Surgery may not prolong life in men with early-stage prostate cancer

Surgery may not prolong life in men with early-stage prostate cancer

Neolys Diagnostics announces new precise, rapid blood test to evade radiotherapy side effects

Neolys Diagnostics announces new precise, rapid blood test to evade radiotherapy side effects

Scientists reveal role of cellular prion protein in development of NF2-related tumors

Scientists reveal role of cellular prion protein in development of NF2-related tumors